Editorial
Published on 13 Jun 2023
Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1234219
- 1,431 views
Type at least 3 characters
414 articles
Original Research
Published on 13 Jun 2023
Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218244
- 5,144 views
- 4 citations
Original Research
Published on 12 Jun 2023
Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200017
- 3,585 views
- 12 citations
Original Research
Published on 08 Jun 2023
Comparison of pharmacogenomic information for drug approvals provided by the national regulatory agencies in Korea, Europe, Japan, and the United States
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1205624
- 3,871 views
- 6 citations
Original Research
Published on 08 Jun 2023
The impact of CYP2C19 genotype on phenoconversion by concomitant medication
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1201906
- 7,289 views
- 14 citations
Original Research
Published on 31 May 2023
Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200430
- 3,193 views
- 9 citations
Original Research
Published on 24 May 2023
Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1191129
- 3,681 views
Original Research
Published on 23 May 2023
Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1186824
- 2,168 views
- 3 citations
Original Research
Published on 22 May 2023
The pharmacogenomic landscape of an Indigenous Australian population
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1180640
- 6,168 views
- 11 citations
Review
Published on 18 May 2023
Pharmacogenomics in practice: a review and implementation guide
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1189976
- 32,314 views
- 54 citations
Systematic Review
Published on 16 May 2023
Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1069854
- 3,139 views
- 2 citations
Review
Published on 15 May 2023
Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1184523
- 5,604 views
- 12 citations
Original Research
Published on 15 May 2023
Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1199462
- 3,686 views
- 10 citations
Original Research
Published on 12 May 2023
Identification of a lipid metabolism-related gene for cancer immunotherapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1186064
- 3,127 views
- 1 citation
Original Research
Published on 11 May 2023
An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1175737
- 7,935 views
- 17 citations
Original Research
Published on 11 May 2023
A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1191910
- 4,276 views
- 6 citations